StockData
Elicio Therapeutics, Inc. logo

Elicio Therapeutics, Inc. (ELTX) income statement

ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$1.45−0.05 (-3.33%)

Close on Nov 20, 2026Market cap $38.11MP/E –Yield –

See a number that looks wrong?